Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates

Citation
A. Rubinstein et al., Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates, J ACQ IMM D, 22(5), 1999, pp. 467-476
Citations number
53
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
ISSN journal
15254135 → ACNP
Volume
22
Issue
5
Year of publication
1999
Pages
467 - 476
Database
ISI
SICI code
1525-4135(199912)22:5<467:IROHSS>2.0.ZU;2-D
Abstract
V3 loop peptide sequences from several HIV-1 strains were covalently linked to purified protein derivative (PPD) of Mycobacterium tuberculosis. A mixt ure of PPD conjugates of V3 loop peptides from six different strains of HIV -1 induced a stronger antibody response than a single V3 peptide-conjugate administered to guinea pigs and humans. Sera from animals immunized with a PPD-six peptide-PPD conjugate neutralized multiple primary-isolate strains of HIV-l, Potent immune responses were noted only when animals were primed with bacillus Calmette-Guerin (BCG), PPD was covalently bound to the peptid es, and PPD was used as the carrier protein. Based on these animal studies, an immunogen consisting of PPD-conjugated V3 loop peptides from five HIV-1 strains was tested in 7 HIV-1 seropositive PPD skin test-positive study su bjects, Vaccinees exhibited over rime a uniform increase in neutralizing an tibodies for both laboratory adapted and primary isolates of HIV-1, includi ng strains from multiple clades. In 3 patients with baseline viral loads be tween 8000 and 12,000 RNA copies/ml, the viral load declined in 2 patients to <400 copies/ml and in 1 patient to 1200 copies/ml without concurrent adm inistration of highly active anti-retroviral therapy (HAART).